Inhibition of Small-cell Lung Cancer Angiogenesis by Irinotecan Metronomic Chemotherapy and Irinotecan Plus Everolimus
Daily administration of CPT-11 may have significant antitumor effects based on its anti-angiogenic effects. Daily administration of CPT-11 may be a novel second-line option for SCLC.
Authors
- Takeshi Isobe (ORCID: https://orcid.org/0000-0002-3498-9772)
- Rong Sun (ORCID: https://orcid.org/0000-0003-4269-7056)
- Tamio Okimoto (ORCID: https://orcid.org/0000-0001-8295-1296)
- Yukari Tsubata (ORCID: https://orcid.org/0000-0002-4260-2849)
- Ryosuke Tanino (ORCID: https://orcid.org/0000-0002-5148-9526)
- Yoshimasa Amano (ORCID: https://orcid.org/0000-0002-7233-2261)
Institutions
- Shimane University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-11-29
- DOI
- https://doi.org/10.21873/anticanres.17868
- Citations
- 1
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.05